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Background:  Providing antenatal and postnatal care for women who drink alcohol in pregnancy is 
only possible if those at risk can be identified.  We aimed to detect the prevalence of actual and self-
reported alcohol consumption in pregnant women in the first trimester of pregnancy. We also 
compared the utility of self-report to blood biomarker analysis.    
Methods: Routine blood testing is offered at the antenatal booking appointment (uptake 95%). 600 
random blood samples were analysed by Helena Biosciences from each month of 2014 to illustrate 
any seasonal variation. We tested an aliquot (0.5 mL serum/plasma) of anonymised blood for 
Carbohydrate Deficient Transferrin (CDT), a validated marker of chronic alcohol consumption 
(normalising 2-4 weeks from the start of abstinence).  Frequency of alcohol consumption during 
pregnancy is currently based on self-report. We collected data from medical records on women’s 
reported alcohol consumption.  We analysed and compared the self-reported alcohol consumption 
documented in the booking notes using the Audit-C alcohol screening tool of 600 randomly selected 
medical records. Results: The percentage of women who reported drinking alcohol in pregnancy was 
1%. This compared to 61% who reported consuming alcohol before pregnancy. The CDT results 
revealed an alcohol prevalence rate of 1.3% which corresponds with the self-reported alcohol in 
pregnancy results and current literature estimating a 1% prevalence rate of FASD births.  
Conclusions:  Most women screened antenatally at their booking visit using the audit C reported 
similar levels of alcohol consumption than were indicated by their blood biomarkers obtained at the 
same visit. However, CDT may not detect the low level drinkers. Therefore, further studies using 
additional blood biomarkers may be beneficial in detecting a more detailed drinking history.    
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